‘Biggest’ leap in identified lung health genes paves way for personalised risk score

Over 500 new genes have been linked to lung function for the first time, allowing a better understanding of  lung disease. The study, led by the University of Leicester and University of Nottingham, is the...

Forging advances in the treatment of respiratory diseases

In this issue of BioScience Today, we speak to Professor Martin Gosling, about the inspiration behind his work, what motivates him daily, and the advances in the treatment of respiratory diseases that he is...

UCL supports worldwide dissemination of free-to-access manufacturing instructions for COVID-19 breathing aids

Governments across the world, healthcare providers and device manufacturers can now request a free of charge licence to the design and manufacturing files of a breathing aid developed by UCL, UCLH and Mercedes-AMG High...

Helping everyone breathe easier – finding new approaches to treating respiratory disease

Everyone should be able to breathe clean air with healthy lungs, yet sadly far too many people continue to gasp for breath because of lung disease. In the UK, one in five people develop...

Exciting times in the field of asthma research

One of the areas in which truly exciting advances are being made is asthma, one of the commonest chronic diseases on the planet. Professor Stephen Holgate, CBE, Chair of the Research Committee of the British...

UK accounts for over 12% of global cell and gene therapy clinical trials

The UK and the NHS are providing the right environment and infrastructure to allow innovative cell and gene therapies to reach patients. International companies recognise the appeal of the UK cell and gene therapy...

Limiting damage from an asthma attack could stop disease

Scientists at King’s College London have discovered a new cause for asthma that sparks hope for treatment that could prevent the life-threatening disease. Most current asthma treatments stem from the idea that it is an...

Getting more out of our medicines – re-purposing drugs to improve patient care

Paul Chrisp, Programme Director Medicines and Technologies, NICE Developing new medicines and then ensuring they are used appropriately is a costly and drawn out process. The NHS needs to make sure that alongside the development...